A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Twin Health Secures $53M to Accelerate AI Digital Twin for Metabolic HealthHealthradar22. August 2025 What You Should Know: – Twin Health, a company focused on using AI digital twin technology for metabolic health, has…
